Skip to main content

Find Clinical Trials

Home
Conditions
Respiratory Tract Neoplasms

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,148 public trials 1,871 recruiting studies

Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Completed

Lung Cancer Mutation Consortium Protocol

NCT01014286

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of Lung, Stage IV, +8 more
Locations: University of Colorado Denver Cancer Center Aurora, Colorado, United States

View Trial Details

Completed

Study of Durvalumab Following Radiation Therapy in Patients With Stage 3 Unresectable NSCLC Ineligible for Chemotherapy

NCT04249362

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Research Site Tucson, Arizona, United States

Research Site Tampa, Florida, United States

Research Site Royal Oak, Michigan, United States

Research Site Limoges, France

View all 35 locations

View Trial Details

Completed

Mini Invasive Endomicroscopy of the Pleura for Malignancies Diagnosis

NCT04731129

Conditions: Neoplasms, Neoplasms by Site, Pleural Diseases, +4 more
Locations: Olivier Bonhomme Liège, Belgium

View Trial Details

Completed

National Comprehensive Cancer Network (NCCN) Decision Support Tool for Patients With NSCLC

NCT03982459

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Completed

Ipilimumab and Nivolumab in Patients With Anti-PD-1-axis Therapy-resistant Advanced Non-small Cell Lung Cancer.

NCT03262779

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations: Yale Cancer Center New Haven, Connecticut, United States

View Trial Details

Completed

Universal Cancer Peptide-based Vaccination in Metastatic NSCLC

NCT02818426

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Centre Hospitalier Régional Universitaire de Besançon Besançon, France

Centre Georges François Leclerc Dijon, France

Hôpital Emile Muller Mulhouse, France

St Louis Hospital Paris, France

View Trial Details

Completed

Efficacy Study Comparing ZD6474 in Combination With Pemetrexed and Pemetrexed Alone in 2nd Line NSCLC Patients

NCT00418886

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Research Site Casa Grande, Arizona, United States

Research Site Chandler, Arizona, United States

Research Site Farmington, Connecticut, United States

Research Site Stamford, Connecticut, United States

View all 110 locations

View Trial Details

Completed

Non-interventional Study for Real-world Data of Afatinib Treatment in First-line Setting and of Subsequent Therapies for Patients With Advanced Epidermal Growth Factor Receptor (EGFR) Mutation-positive Lung Adenocarcinoma

NCT04795245

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Nippon Boehringer Ingelheim Co., Ltd. Tokyo, Japan

View Trial Details

Completed

Dyadic Psychological Stress Among Lung Cancer Patient-caregiver Dyads

NCT06746948

Conditions: Lung Cancer Patients, Lung Cancers, Lung Diseases, +6 more
Locations: Xiangya School of Nursing Changsha, China

View Trial Details

Completed

A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors

NCT04731467

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +48 more
Locations: HonorHealth Research Institute Scottsdale, Arizona, United States

University of Colorado Aurora, Colorado, United States

Yale University New Haven, Connecticut, United States

Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View all 18 locations

View Trial Details